Symbicort 80/4.5mcg (120 Oral Inh)

Manufacturer ASTRA ZENECA Active Ingredient Budesonide and Formoterol Inhalation Aerosol(byoo DES oh nide & for MOH te rol) Pronunciation byoo DES oh nide & for MOH te rol
It is used to treat COPD (chronic obstructive pulmonary disease).It is used to treat asthma.Do not use this drug to treat intense flare- ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
đŸˇī¸
Drug Class
Inhaled Corticosteroid (ICS) / Long-Acting Beta2-Agonist (LABA) Combination
đŸ§Ŧ
Pharmacologic Class
Glucocorticoid / Selective Beta2-Adrenergic Agonist
🤰
Pregnancy Category
C
✅
FDA Approved
Jul 2006
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Symbicort is an inhaler that contains two medicines: budesonide and formoterol. Budesonide is a steroid that helps reduce inflammation in your lungs, making it easier to breathe. Formoterol is a bronchodilator that helps open up your airways. It's used regularly, twice a day, to help control asthma or COPD symptoms and prevent flare-ups. It is NOT for sudden breathing problems.
📋

How to Use This Medicine

Proper Use of Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only. Continue using it as directed by your doctor or healthcare provider, even if you feel well.

Preparing and Using Your Inhaler

Before using your inhaler for the first time, or if it has not been used for more than 7 days, or if it has been dropped, prepare it by spraying 2 test sprays into the air. Shake the inhaler well for 5 seconds before each test spray. Before each use, shake the inhaler well for 5 seconds. After using your inhaler, rinse your mouth with water, but do not swallow the water. Spit it out. Replace the cap on the inhaler after each use.

Tracking Your Doses

Your inhaler has a dose counter that keeps track of how many doses are left. Dispose of the inhaler when you are told to do so after opening, or when the dose counter reaches "0", whichever comes first. Never wash the inhaler, and keep it dry.

Using Multiple Inhaled Medications

If you are using more than one inhaled medication, ask your doctor which one to use first.

Accidental Exposure

If you accidentally get the medication in your eyes, rinse them immediately with water. If you experience eye irritation that lasts or a change in vision, contact your doctor.

Storage and Disposal

Store your medication at room temperature. Discard any unused portion 3 months after removing it from the foil package. Protect the medication from heat or open flames. Do not puncture or burn the inhaler, even if it seems empty.

Missing a Dose

If you miss a dose, skip it and return to your regular schedule. Do not use two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Use Symbicort regularly, twice a day, every day, even if you feel well.
  • Do NOT use Symbicort for sudden breathing problems; use your prescribed rescue inhaler for that.
  • Rinse your mouth with water and spit it out after each dose to help prevent oral thrush (a fungal infection in the mouth).
  • Do not swallow the water after rinsing.
  • Keep track of the number of inhalations used and discard the inhaler after the labeled number of actuations or expiration date.
  • Avoid your asthma/COPD triggers (e.g., smoke, allergens, pollution).
  • Maintain good hydration and a healthy lifestyle.
  • Attend regular follow-up appointments with your doctor.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 2 inhalations twice daily (morning and evening), approximately 12 hours apart
Dose Range: 2 - 2 mg

Condition-Specific Dosing:

asthmaMaintenance: 2 inhalations twice daily
COPDMaintenance: 2 inhalations twice daily
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: For asthma in patients 6 to <12 years of age: 2 inhalations twice daily
Adolescent: For asthma in patients 12 years of age and older: 2 inhalations twice daily
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dose adjustment recommended
Moderate: No dose adjustment recommended
Severe: No dose adjustment recommended
Dialysis: Not specifically studied; systemic exposure is low, so significant impact is unlikely.

Hepatic Impairment:

Mild: Use with caution; no specific dose adjustment recommended
Moderate: Use with caution; consider monitoring for increased systemic corticosteroid effects
Severe: Use with caution; consider monitoring for increased systemic corticosteroid effects and potential dose reduction if adverse effects occur

Pharmacology

đŸ”Ŧ

Mechanism of Action

Budesonide is a potent glucocorticoid with anti-inflammatory properties. It reduces inflammation in the airways, decreasing bronchial hyperreactivity and mucus production. Formoterol is a long-acting selective beta2-adrenergic agonist (LABA) that stimulates beta2-receptors in the bronchial smooth muscle, leading to bronchodilation and relaxation of the airways. The combination provides both anti-inflammatory and bronchodilator effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Budesonide: ~10-15% (systemic after inhalation); Formoterol: ~10% (systemic after inhalation)
Tmax: Budesonide: ~10-30 minutes; Formoterol: ~10 minutes
FoodEffect: Not applicable for inhaled administration

Distribution:

Vd: Budesonide: ~3 L/kg; Formoterol: ~4 L/kg
ProteinBinding: Budesonide: ~85-90%; Formoterol: ~50%
CnssPenetration: Limited

Elimination:

HalfLife: Budesonide: ~2-3 hours; Formoterol: ~10 hours
Clearance: Budesonide: ~84 L/hr; Formoterol: ~139 L/hr
ExcretionRoute: Budesonide: Urine (60%) and feces; Formoterol: Urine (60%) and feces
Unchanged: Budesonide: <1% in urine; Formoterol: ~7% in urine
âąī¸

Pharmacodynamics

OnsetOfAction: Formoterol: Within 1-3 minutes (bronchodilation); Budesonide: Full anti-inflammatory effect may take days to weeks
PeakEffect: Formoterol: Within 1-2 hours; Budesonide: Varies, sustained over time with regular use
DurationOfAction: Formoterol: Up to 12 hours; Budesonide: Sustained with twice-daily dosing

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as formoterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma showed that LABAs increase the risk of asthma-related death. This finding is considered a class effect of LABA. The safety and effectiveness of SYMBICORT in patients with asthma have not been established in patients <6 years of age.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of high blood sugar, such as:
+ Confusion
+ Drowsiness
+ Excessive thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ Abnormal heartbeat
Signs of a weak adrenal gland, such as:
+ Severe nausea or vomiting
+ Severe dizziness or fainting
+ Muscle weakness
+ Fatigue
+ Mood changes
+ Decreased appetite
+ Weight loss
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Fainting
+ Changes in vision
Chest pain or pressure
Rapid or irregular heartbeat
Shakiness
Nervousness or excitability
Bone pain
Dizziness or fainting
Seizures
Severe nausea or vomiting
Fatigue or weakness
Sleep disturbances
Abnormal sensations, such as burning, numbness, or tingling
Flu-like symptoms
Sinus pain
Changes in vision, eye pain, or severe eye irritation
Redness or white patches in the mouth or throat
Mouth irritation or sores

Breathing Problems: A Life-Threatening Side Effect

This medication can cause severe breathing problems, which may be life-threatening. If you experience trouble breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you notice any of the following:

Headache
Stomach pain
Nose or throat irritation
Common cold symptoms
Back pain
Nausea or vomiting

These are not all the possible side effects that may occur. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for your rescue inhaler
  • Chest pain or fast/irregular heartbeat
  • Severe headache or dizziness
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • Signs of allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, difficulty breathing)
  • Vision changes (e.g., blurred vision, halos around lights)
  • Unusual tiredness, weakness, or weight loss (signs of adrenal suppression)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking another medication similar to this one. If you are unsure, consult your doctor or pharmacist for clarification.

To ensure your safety, it is crucial to disclose all of your medications, including:

Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins

Additionally, inform your doctor about any existing health problems. This information will help your doctor determine whether it is safe for you to take this medication in conjunction with your other medications and health conditions.

Remember, this is not an exhaustive list of potential interactions. Therefore, it is vital to verify the safety of taking this medication with all of your medications and health problems. Never start, stop, or modify the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

Before taking this medication, inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

If you have diabetes (high blood sugar), consult your doctor, as this medication may increase your blood sugar levels. It may take up to 2 weeks to experience the full effects of this medication.

Monitoring and Emergency Situations

Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently. Do not exceed the prescribed dose or frequency, as overdosing on this type of medication can be fatal. Consult your doctor if you have any concerns.

Transitioning from Oral Steroids

When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and seek medical attention immediately if you experience any of these.

In cases of injury, surgery, or infection, you may require additional oral steroid doses to help your body cope with stress. Carry a warning card indicating that you may need extra steroids in certain situations.

Long-term Use and Potential Side Effects

Prolonged use of this medication may increase the risk of developing cataracts or glaucoma. Schedule regular eye exams as recommended by your doctor.

Long-term use may also lead to osteoporosis (weak bones). Discuss your risk factors and any concerns with your doctor.

You may be more susceptible to infections; therefore, practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.

Special Precautions

If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed, consult your doctor promptly.

If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

In children and teenagers, this medication may affect growth in some cases. Regular growth checks may be necessary; consult your doctor for guidance.

Pregnancy, Breastfeeding, and COPD

If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor.

If you have chronic obstructive pulmonary disease (COPD), be aware that your risk of developing pneumonia is higher. This medication may further increase this risk; consult your doctor to discuss the potential risks and benefits.
🆘

Overdose Information

Overdose Symptoms:

  • Budesonide: Signs of hypercorticism (e.g., moon face, central obesity, easy bruising, muscle weakness, fatigue), adrenal suppression.
  • Formoterol: Tachycardia, palpitations, tremor, headache, nausea, dizziness, hypokalemia, hyperglycemia, metabolic acidosis.

What to Do:

Seek immediate medical attention. Treatment is supportive and symptomatic. Consider cardiac monitoring for formoterol overdose. For budesonide overdose, chronic overdose may lead to adrenal suppression, requiring gradual withdrawal of therapy under medical supervision. Call 1-800-222-1222 (Poison Control).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Acute bronchospasm or status asthmaticus (Symbicort is not a rescue inhaler)
  • Primary treatment of severe acute attacks of asthma or COPD
🔴

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin) - may increase systemic exposure to budesonide
  • Other long-acting beta2-agonists (LABAs) - additive effects, increased risk of adverse cardiovascular events
  • Non-selective beta-blockers (e.g., propranolol) - may antagonize the effect of formoterol and cause severe bronchospasm
🟡

Moderate Interactions

  • Diuretics (e.g., loop or thiazide diuretics) - may potentiate hypokalemia and/or ECG changes associated with beta-agonists
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs) - may potentiate the cardiovascular effects of formoterol
  • QTc-prolonging drugs (e.g., quinidine, disopyramide, procainamide, phenothiazines, antihistamines) - increased risk of ventricular arrhythmias
đŸŸĸ

Minor Interactions

  • Not typically listed as clinically significant for this combination

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pulmonary Function Tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess disease severity

Timing: Prior to initiation of therapy

Asthma/COPD Control Assessment

Rationale: To establish baseline symptom burden and quality of life

Timing: Prior to initiation of therapy

Growth monitoring (pediatric patients)

Rationale: To assess potential systemic corticosteroid effects on growth

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Asthma/COPD Control Assessment

Frequency: Regularly (e.g., every 3-6 months or as clinically indicated)

Target: Well-controlled symptoms, minimal rescue inhaler use

Action Threshold: Increased symptoms, increased rescue inhaler use, nocturnal awakenings, activity limitation

Pulmonary Function Tests (e.g., FEV1)

Frequency: Periodically (e.g., every 6-12 months or as clinically indicated)

Target: Stable or improved lung function

Action Threshold: Significant decline in FEV1

Oral Cavity Inspection

Frequency: At each visit

Target: Absence of white patches or lesions

Action Threshold: Presence of oral candidiasis (thrush)

Growth monitoring (pediatric patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age

Action Threshold: Growth deceleration

Ocular examination (for long-term high-dose use)

Frequency: Annually or as clinically indicated

Target: Absence of cataracts or glaucoma

Action Threshold: Changes in vision, signs of cataracts or glaucoma

đŸ‘ī¸

Symptom Monitoring

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for rescue inhaler (short-acting beta2-agonist)
  • Oral candidiasis (white patches in mouth or throat)
  • Hoarseness or dysphonia
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain, fatigue, mood changes)
  • Signs of paradoxical bronchospasm (immediate worsening of breathing after inhalation)
  • Cardiovascular symptoms (e.g., palpitations, chest pain, rapid heart rate, tremor)
  • Vision changes (e.g., blurred vision, halos around lights)

Special Patient Groups

🤰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Budesonide is generally considered safer than other inhaled corticosteroids during pregnancy (Category B for budesonide alone), while formoterol is Category C. The combination is typically classified as Category C.

Trimester-Specific Risks:

First Trimester: Limited data, but generally considered low risk for budesonide. Formoterol risk is theoretical.
Second Trimester: No specific increased risks identified.
Third Trimester: No specific increased risks identified. Monitor for signs of labor inhibition or neonatal hypoglycemia/tachycardia with LABAs, though unlikely with inhaled doses.
🤱

Lactation

Budesonide is excreted in breast milk but is considered compatible with breastfeeding due to low systemic absorption and low infant exposure. Formoterol excretion into human milk is unknown, but systemic levels are low. Use with caution; weigh benefits of breastfeeding against potential risks to the infant.

Infant Risk: Low risk for budesonide; potential but likely low risk for formoterol due to low systemic exposure.
đŸ‘ļ

Pediatric Use

Approved for asthma in patients 6 years of age and older. Monitor growth velocity regularly, as inhaled corticosteroids can affect growth. The lowest effective dose should be used.

👴

Geriatric Use

No specific dose adjustment is required. However, elderly patients may be more susceptible to the cardiovascular effects of formoterol or systemic corticosteroid effects of budesonide due to comorbidities or polypharmacy. Monitor for adverse effects.

Clinical Information

💎

Clinical Pearls

  • Symbicort is a maintenance medication and should not be used for acute relief of bronchospasm. Patients should have a short-acting beta2-agonist (SABA) for rescue.
  • Proper inhaler technique is crucial for efficacy. Patients should be instructed on how to use the inhaler correctly and to rinse their mouth after each dose to prevent oral candidiasis.
  • The black box warning for LABAs regarding increased risk of asthma-related death applies to Symbicort. It should only be used in asthma patients for whom the benefits of an ICS/LABA combination outweigh the risks, or who are not adequately controlled on an ICS alone.
  • Patients should be advised not to stop Symbicort abruptly, especially if on high doses, due to the risk of adrenal insufficiency.
  • Monitor for signs of systemic corticosteroid effects, especially in children (growth) and patients on high doses or with predisposing factors (e.g., osteoporosis, glaucoma, cataracts, diabetes).
🔄

Alternative Therapies

  • Inhaled Corticosteroids (ICS) monotherapy (e.g., Pulmicort Flexhaler, Flovent HFA/Diskus)
  • Long-Acting Beta2-Agonists (LABA) monotherapy (e.g., Serevent Diskus, Arcapta Neohaler) - generally not recommended for asthma without an ICS
  • Long-Acting Muscarinic Antagonists (LAMA) (e.g., Spiriva HandiHaler/Respimat)
  • Oral corticosteroids (for severe exacerbations)
  • Leukotriene receptor antagonists (e.g., montelukast)
  • Biologic therapies (e.g., omalizumab, mepolizumab, benralizumab, dupilumab) for severe asthma
💰

Cost & Coverage

Average Cost: $300 - $450 per 120 actuations inhaler
Insurance Coverage: Tier 2 or Tier 3 (Preferred Brand or Non-Preferred Brand)
📚

General Drug Facts

If your symptoms or health condition do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it is a good idea to consult with your pharmacist for more information. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the name of the medication taken, the amount consumed, and the time it occurred.